WIPO Patent Law Committee Agrees On Future Work, Stays On Safe Path 15/12/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The mood was conciliatory this week at the World Intellectual Property Organization patent law committee as delegates mainly shared experiences and heard presentations. The five topics composing the work of the committee, which had been carefully negotiated in the summer and reflecting a “delicate balance” of interest between countries, will be pursued at the next session. Among them are the topics of patents and health, technology transfer, and the quality of patents.
Intellectual Property Rights In Trade – To Be Rethought? 15/12/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment After two decades of intellectual property regimes in trade agreements, one could have some second thoughts, according to a number of panellists at the Trade and Sustainable Development Symposium, organised by the International Centre for Trade and Sustainable Development (ICTSD) and held alongside the 11th World Trade Organization Ministerial in Buenos Aires, Argentina this week.
London Declaration Report Shows Progress But More Needed Against Neglected Tropical Diseases 15/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A newly released report by the wide-ranging joint London Declaration initiative to fight neglected tropical diseases shows progress in elimination of diseases and the number of people treated. However, in order to reach universal health coverage, efforts have to be intensified, according to the World Health Organization director general. The pharmaceutical industry, meanwhile, said it is ready to live up to its pledge made five years ago and expand donations programmes.
Former Medicines Patent Pool Head Greg Perry Joins Pharmaceutical Industry 15/12/2017 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment A day after Greg Perry resigned as executive director of the Medicines Patent Pool, the pharmaceutical industry announced today that he will join the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as an assistant director general.
Obviousness In The Wake Of Arendi 15/12/2017 by Intellectual Property Watch Leave a Comment Since the U.S. Court of Appeals for the Federal Circuit issued its opinion in Arendi S.A.R.L. v. Apple Inc. last August,[1] many patent commentators have asserted that the decision marked a significant change in the analysis of obviousness under 35 U.S.C. § 103, especially as a weakening of single-reference obviousness grounds. Notwithstanding this decision, petitioners and the Patent Trial and Appeal Board have continued to rely on single-reference obviousness to assert and find that claims are obvious, write Amy Simpson and Kyle Canavera.
WIPO Gives Overview Of Its Legislative Assistance To Developing Countries 14/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization provides legislative assistance to countries upon request. This week during the meeting of the Standing Committee on the Law of Patents, the secretariat explained how WIPO provides this legislative assistance. This followed a 2015 proposal to revise WIPO’s 1979 Model Law for developing countries on inventions. The proposal was not accepted by developed countries concerned over the extent of the task, and some pointing out that WIPO is delivering more effective tailored legislative assistance.
WTO Ministerial Unable To Cut Deals; Members Set Up Plurilateral Groups On E-Commerce, Other Issues 14/12/2017 by Monika Ermert for Intellectual Property Watch 1 Comment The 11th Ministerial Conference of the World Trade Organization (MC11) ended without a joint ministerial declaration and without progress in some of the important agenda points on the table. Instead several groups of “friends” announced they would push ahead independently, with 71 members including the United States and the European Union announcing they will “initiate exploratory work together toward future WTO negotiations on trade related aspects of electronic commerce.”
Greg Perry Resigns As Director Of Medicines Patent Pool 14/12/2017 by William New, Intellectual Property Watch 1 Comment After nearly five years as the executive director of the Medicines Patent Pool, Greg Perry has stepped down with little notice. [Update: the next day, it was announced that he has joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva.]
WIPO Delegates Told Patent Information Essential, Given Revealing Data On Medicines Access and Trade 14/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment World Intellectual Property Organization patent law committee delegates heard a number of presentations this week on the relationship between patents and health, and access to medicines. The importance of patent information and accurate, up-to-date databases was underlined, particularly for procurement. The weight of intellectual property rights on the issue of access to medicines and prices and generic market entry was pointed out, but so were other factors, such as the small percentage of new drugs with added benefit, tariffs, and trade delays.
G-Finder Report: Global Funding For R&D In Neglected Diseases Increasing, Overreliance On US Funding Dangerous 13/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is “unparalleled,” and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found.